logo-loader
viewMota Ventures

Mota Ventures to enter vibrant psychedelics space as it inks deal with German psilocybin manufacturer

Verrian’s focus is to treat patients suffering from addition through the microdosing of psilocybin

Mota Ventures -
The proposed deal to acquire Verrian is worth around C$21.2 million

Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) told shareholders Wednesday that it has signed a letter of intent to acquire German psychedelic medicine company Verrian Ontario Ltd in a proposed deal worth C$21.1 million.

Verrian owns and operates an EU-GMP, ISO 14001 compliant 110,000 square foot facility in Radebuel, Germany that was a former pharmaceutical manufacturing centre. The company develops products related to addition reduction.

Verrian’s focus is to treat patients suffering from addition through the microdosing of psilocybin, a naturally occurring psychedelic compound produced by more than 200 species of mushrooms.

READ: Mota Ventures posts record 39% jump in revenue in April driven by demand for natural health solutions

The firm’s facility is estimated to be worth around C$10.6 million, including an analytical laboratory and a full pharmaceutical manufacturing suite, Mota told shareholders. In addition, Verrian invested around C$2.4 million into clinical trial design and developing proprietary formulations of its patented PSI-GEN psilocybin formulations and cannabis products.

“I am extremely excited at the opportunity to acquire an established psychedelic medicine company in Europe,” Mota’s CEO Ryan Hoggan told investors in a statement.

“As an innovative company, Mota always seeks to be a leader in the natural health space and we see the psychedelic medicine market becoming a major part of the industry. This acquisition allows us to have first mover advantage in the psychedelic market, and Mota’s existing distribution network will be ready to capitalize on the opportunity once regulation has been put in place.”

Under the terms of the proposed transaction, Mota would acquire all of privately-held Verrian’s shares for C$21.1 million, of which C$20 million would be comprised of Mota shares. The balance would be payable in cash.

Mota Ventures is an ecommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Mota Ventures

Price: 0.245 CAD

CSE:MOTA
Market: CSE
Market Cap: $23.93 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Mota Ventures named herein, including the promotion by the Company of Mota Ventures in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Mota Ventures sees strong sales increase amid COVID-19 Crisis

Mota Ventures (CSE: MOTA-OTCMKTS: PEMTF) CEO Ryan Hoggan joined Steve Darling from Proactive Vancouver to discuss how the company is doing during the Corona Virus crisis and how it has affected sales. Hoggan also told Proactive about a new product line the company has started and how excited...

on 1/4/20

2 min read